Clinical Trial Site Search & Selection — Latin America — bioaccess®

bioaccess® identifies, qualifies, and activates clinical trial sites across Latin America for first-in-human and early-feasibility studies. Our network spans 50+ pre-qualified research sites across 19 Latin American & Caribbean countries.

What the service includes

• Principal investigator identification and engagement matched to your therapeutic area and device or drug.
• Site qualification and feasibility assessment — infrastructure, patient population, prior study experience, and regulatory standing.
• Site activation — ethics-committee and regulatory submissions, contracts and budgets, and study-startup coordination.
• Ongoing site management and monitoring under ISO 14155 (devices) or ICH E6 (drugs).

Why Latin America

Access to large patient populations with significant unmet clinical need, under full ethics-committee oversight, with ethics approvals typically obtained in 4–8 weeks (varies by country and committee), lets early-stage studies reach first human data meaningfully faster and at a lower per-patient cost than comparable U.S./EU programs. Individual timelines and costs vary and are not guaranteed; data quality is maintained under ISO 14155 GCP to support eligibility for FDA acceptance under 21 CFR 812.28.

Related: Clinical trial services · Case studies · Regulatory guide

Contact bioaccess® · Book a Meeting